Phillips 66 (NYSE:PSX – Get Free Report) had its target price cut by stock analysts at Piper Sandler from $151.00 to $136.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has an “overweight” rating on the oil and gas company’s stock. Piper Sandler’s price target indicates a potential upside of […]

Phillips 66 (NYSE:PSX – Free Report) – Analysts at Zacks Research increased their Q1 2025 earnings per share (EPS) estimates for Phillips 66 in a report issued on Tuesday, September 17th. Zacks Research analyst R. Department now expects that the oil and gas company will post earnings per share of $2.33 for the quarter, up […]

Independent Bank Group (NASDAQ:IBTX – Get Free Report) had its price objective hoisted by analysts at Truist Financial from $65.00 to $66.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “hold” rating on the bank’s stock. Truist Financial’s target price would suggest a potential upside of 12.19% from the […]

Exelon (NASDAQ:EXC – Get Free Report) had its price objective hoisted by UBS Group from $40.00 to $43.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price objective would indicate a potential upside of 6.78% from the company’s current price. […]

4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) had its target price hoisted by Chardan Capital from $38.00 to $39.00 in a research report report published on Thursday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages have also recently weighed in on FDMT. BMO Capital Markets reduced […]

Stanley Black & Decker, Inc. (NYSE:SWK – Free Report) – Zacks Research dropped their FY2025 earnings per share (EPS) estimates for shares of Stanley Black & Decker in a note issued to investors on Tuesday, September 17th. Zacks Research analyst R. Department now expects that the industrial products company will post earnings per share of […]

Applied Therapeutics (NASDAQ:APLT – Free Report) had its price target hoisted by Leerink Partners from $11.00 to $14.00 in a research note issued to investors on Thursday morning, Benzinga reports. Leerink Partners currently has an outperform rating on the stock. A number of other equities analysts also recently weighed in on the company. Royal Bank […]

The Charles Schwab Co. (NYSE:SCHW – Free Report) – Stock analysts at Zacks Research decreased their Q2 2026 earnings per share estimates for Charles Schwab in a report released on Tuesday, September 17th. Zacks Research analyst R. Department now forecasts that the financial services provider will post earnings per share of $1.15 for the quarter, […]